Skip to main content

BioMicro Systems, Infineon, Axon Instruments


BioMicro Systems of Salt Lake City, Utah, last week introduced a semi-automated MAUI hybridization system. The company said it improves sensitivity for low-abundance genes over traditional methods of hybridization for microarray analysis. The new system allows users to simultaneously process up to four standard microarrays with controlled heating and mixing.


Infineon of Munich, Germany, will introduce its Flow-Thru Chip system this week. The system, which includes biochips and instruments, sells for €60,000 ($63,000) and is available in kits for inflammation, cancer (lung and breast), and neurological diseases such as Alzheimer’s, Parkinson’s and MS. The system includes biochips, a hybridization unit, and a CCD camera and system for data collection.


Axon Instruments is introducing the 4200A, a fully configurable four-color scanner (see page 3).

The Scan

Pfizer-BioNTech Seek Full Vaccine Approval

According to the New York Times, Pfizer and BioNTech are seeking full US Food and Drug Administration approval for their SARS-CoV-2 vaccine.

Viral Integration Study Critiqued

Science writes that a paper reporting that SARS-CoV-2 can occasionally integrate into the host genome is drawing criticism.

Giraffe Species Debate

The Scientist reports that a new analysis aiming to end the discussion of how many giraffe species there are has only continued it.

Science Papers Examine Factors Shaping SARS-CoV-2 Spread, Give Insight Into Bacterial Evolution

In Science this week: genomic analysis points to role of human behavior in SARS-CoV-2 spread, and more.